Biohaven Ltd. - Common Shares, no par value (BHVN) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2022 to Q4 2025

Type / Class
Equity / Common Shares, no par value
Symbol
BHVN on NYSE
Shares outstanding
131,883,808
Price per share
$12.87
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
118,455,840
Total reported value
$1,337,551,556
% of total 13F portfolios
0.01%
Share change
+32,896,914
Value change
+$338,664,807
Number of holders
263
Price from insider filings
$12.87
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Biohaven Ltd. - Common Shares, no par value (BHVN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 13% +105% $189,711,052 +$113,253,896 16,803,459 +148% JANUS HENDERSON GROUP PLC 30 Jan 2026
SUVRETTA CAPITAL MANAGEMENT, LLC 7.8% $116,139,519 10,286,937 SUVRETTA CAPITAL MANAGEMENT, LLC 31 Dec 2025
VANGUARD GROUP INC 2.7% $43,156,602 2,875,190 The Vanguard Group 30 Sep 2025

As of 31 Dec 2025, 263 institutional investors reported holding 118,455,840 shares of Biohaven Ltd. - Common Shares, no par value (BHVN). This represents 90% of the company’s total 131,883,808 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Biohaven Ltd. - Common Shares, no par value (BHVN) together control 62% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
SUVRETTA CAPITAL MANAGEMENT, LLC 7.8% 10,286,937 +83% 2.9% $116,139,519
STIFEL FINANCIAL CORP 7.5% 9,939,856 +50% 0.1% $112,220,980
BlackRock, Inc. 7.2% 9,448,040 +20% 0% $106,668,371
INFINITUM ASSET MANAGEMENT, LLC 4.7% 6,250,000 +268% 10% $70,562,500
STATE STREET CORP 4.3% 5,716,487 +34% 0% $64,539,138
TCG Crossover Management, LLC 3.5% 4,631,317 1.7% $52,287,569
VANGUARD GROUP INC 3.3% 4,395,946 +53% 0% $49,630,230
D. E. Shaw & Co., Inc. 2% 2,694,234 +113% 0.02% $30,417,901
FMR LLC 2% 2,682,234 +11% 0% $30,282,423
GEODE CAPITAL MANAGEMENT, LLC 1.8% 2,392,277 +16% 0% $27,014,387
BNP PARIBAS FINANCIAL MARKETS 1.6% 2,093,816 0% 0.01% $23,639,183
PRICE T ROWE ASSOCIATES INC /MD/ 1.5% 2,018,550 +0.44% 0% $22,790,000
GOLDMAN SACHS GROUP INC 1.5% 1,962,206 +24% 0% $22,153,306
BANK OF AMERICA CORP /DE/ 1.4% 1,792,443 +127% 0% $20,236,682
CITADEL ADVISORS LLC 1.3% 1,743,993 +75% 0.01% $19,689,681
Schonfeld Strategic Advisors LLC 1.2% 1,606,777 +3830% 0.09% $18,140,510
Balyasny Asset Management L.P. 1.2% 1,591,054 +318% 0.03% $17,963,000
Qube Research & Technologies Ltd 1.2% 1,570,610 +24% 0.03% $17,732,187
Integral Health Asset Management, LLC 1.1% 1,500,000 +131% 0.86% $16,935,000
AQR CAPITAL MANAGEMENT LLC 1.1% 1,460,108 +585% 0.01% $16,484,619
JANUS HENDERSON GROUP PLC 1.1% 1,407,365 -79% 0.01% $15,895,313
Capital Research Global Investors 1% 1,332,792 +32% 0% $15,047,222
MILLENNIUM MANAGEMENT LLC 1% 1,324,247 +37% 0.01% $14,950,749
VOLORIDGE INVESTMENT MANAGEMENT, LLC 1% 1,318,775 +758% 0.05% $14,888,970
TWO SIGMA INVESTMENTS, LP 0.95% 1,259,031 +57% 0.02% $14,214,460

Institutional Holders of Biohaven Ltd. - Common Shares, no par value (BHVN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 118,455,840 $1,337,551,556 +$338,664,807 $11.29 263
2025 Q3 84,320,326 $1,263,904,622 -$38,241,337 $15.01 261
2025 Q2 86,987,421 $1,227,652,713 -$143,894,992 $14.11 247
2025 Q1 88,106,650 $2,142,495,070 -$115,214,537 $24.04 260
2024 Q4 89,346,784 $3,336,885,126 +$168,942,579 $37.35 253
2024 Q3 86,165,783 $4,306,353,110 +$148,383,281 $49.97 250
2024 Q2 82,422,187 $2,860,885,986 +$210,746,356 $34.71 222
2024 Q1 74,154,350 $4,055,673,624 +$161,363,053 $54.69 239
2023 Q4 71,802,540 $3,073,238,412 +$434,075,584 $42.80 214
2023 Q3 61,463,892 $1,598,669,852 +$39,755,212 $26.01 183
2023 Q2 60,120,418 $1,438,087,383 -$122,838,089 $23.92 183
2023 Q1 66,543,203 $909,962,550 +$54,642,668 $13.66 171
2022 Q4 62,449,262 $868,331,200 +$266,710,670 $13.88 168
2022 Q3 3,316,172 $499,083,000 +$491,524,000 $151.17 29
2022 Q2 $23.92 0